Pharma Foods, First Half Ordinary Profit Decreases by 58%, Nov-Jan Ordinary Profit Turns to Loss

About Information Provided on This Site

The information provided on our website 'Kabutan.com' is not intended to constitute investment solicitation or investment advisory services.
All investment decisions should be made at your own discretion and judgment.
The data on our website is provided by Tokyo Stock Exchange, Osaka Exchange, Nagoya Securities Exchange, JPX Market Innovation & Research, Japannext, and other sources.
Copyright of the Nikkei Stock Average belongs to Nikkei Inc. Stock price charts displayed on Kabutan.com are provided solely for the purpose of reviewing historical price movements of the securities.
These charts neither suggest nor guarantee future price movements of the securities and do not constitute recommendations to buy or sell.
In our financial results coverage, the term 'Surprise Results' identifies securities that demonstrate a significant degree of surprise in their earnings announcements.
This significance is quantitatively assessed based on multiple factors, including: the nature of the announcement (full-year or quarterly results); types of revisions (earnings or dividend forecasts); and numerical analysis comparing the announced results with both the company's previous forecasts and historical performance.
The 'Surprise Ranking' presents these results in order of their calculated surprise factor. Please note that neither these results nor rankings are intended to suggest or guarantee future performance of the listed securities, nor should they be construed as recommendations to buy or sell.

Wed Mar 12, 2025 1:30 pm JST Earnings

2929 Pharma Foods International Co., Ltd. 【J-GAAP】

Earnings Report

Pharma Foods International Co., Ltd. <2929> [TSE Prime] announced its financial results in the afternoon session on March 12th (13:30). The consolidated ordinary profit for the cumulative second quarter of the fiscal year ending July 2025 (August 2024 to January 2025) significantly dropped 58.2% from the same period last year to 0.64 billion yen. The progress rate toward the full-year plan of 2.3 billion yen was 28.0%, almost the same as the same period of the previous year of 29.4%.

Based on the first-half performance announced by the company and the unchanged full-year plan, our calculation indicates that the consolidated ordinary profit for the February to July period (2H) is expected to significant drop 55.4% from the same period last year to 1.65 billion yen.

In the most recent three-month period, from November to January (2Q), the consolidated ordinary profit/loss turned to a loss of 0.24 billion yen (compared to a profit of 0.93 billion yen in the same period last year). The operating profit/loss margin drastically worsened from 6.0% in the same period last year to -1.7%.

Kabutan News

Actual Results

Accumulated Results 2nd Quarter

Fiscal Year	Revenue	Operating Profit	Ordinary Profit	Net Profit	Adj. EPS	Progress Rate vs. First Half	Announce	Accounting Standards
Aug - Jan, 2022	35,143	-883	-912	-914	-31.6	ー	Mar 7, 2023	J-GAAP
Aug - Jan, 2023	31,652	1,535	1,542	768	26.7	29.4	Mar 11, 2024	J-GAAP
Aug - Jan, 2024	29,857	623	645	229	8.1	28.0	Mar 12, 2025	J-GAAP
YoY	-5.7%	-59.4%	-58.2%	-70.2%	-69.8%

First Half Results vs. Previous Guidance

Fiscal Year	Revenue	Operating Profit	Ordinary Profit	Net Profit	Adj. EPS	Adj. Dividend	Announce	Accounting Standards
Aug - Jan, 2024 Guidance	ー	ー	ー	ー	－	12.50	Sep 12, 2024	J-GAAP
Aug - Jan, 2024 Results	29,857	623	645	229	8.1	12.50	Mar 12, 2025	J-GAAP
Revision Rate	－	－	－	－	－

Current Period Guidance

Second Half Results

Fiscal Year	Revenue	Operating Profit	Ordinary Profit	Net Profit	Adj. EPS	Adj. Dividend	Announce	Accounting Standards
Feb - Jul, 2024	30,495	3,578	3,707	2,437	85.7	15	Sep 12, 2024	J-GAAP
Feb - Jul, 2025 Guidance	35,143	1,377	1,655	1,371	47.2	12.50	Mar 12, 2025	J-GAAP
YoY	+15.2%	-61.5%	-55.4%	-43.7%	-44.9%

Current Period Guidance

Fiscal Year	Revenue	Operating Profit	Ordinary Profit	Net Profit	Adj. EPS	Adj. Dividend	Announce	Accounting Standards
Jul, 2023	68,572	3,610	3,540	3,081	106.7	22	Sep 11, 2023	J-GAAP
Jul, 2024	62,147	5,113	5,249	3,205	112.7	25	Sep 12, 2024	J-GAAP
Jul, 2025 Guidance	65,000	2,000	2,300	1,600	55.1	25	Sep 12, 2024	J-GAAP
YoY	+4.6%	-60.9%	-56.2%	-50.1%	-51.1%

Quarterly Results

Fiscal Year	Revenue	Operating Profit	Ordinary Profit	Net Profit	Adj. EPS	Operating Profit Margin	Announce	Accounting Standards
Nov - Jan, 2023	15,510	934	937	482	16.7	6.0	Mar 11, 2024	J-GAAP
Feb - Apr, 2024	15,519	1,731	1,681	1,088	38.1	11.2	Jun 10, 2024	J-GAAP
May - Jul, 2024	14,976	1,847	2,026	1,349	47.4	12.3	Sep 12, 2024	J-GAAP
Aug - Oct, 2024	14,596	882	888	360	12.9	6.0	Dec 11, 2024	J-GAAP
Nov - Jan, 2024	15,261	-259	-243	-131	-4.6	-1.7	Mar 12, 2025	J-GAAP
YoY	-1.6%	－	－	－	－